Wai Yuen Tong Medicine Holdings Limited (0897.HK)
HKD 0.36
(2.86%)
HKD 0.36
(2.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 308.09 Million HKD | -81.17% |
| 2022 | 1.63 Billion HKD | -12.43% |
| 2021 | 1.86 Billion HKD | -11.75% |
| 2020 | 2.11 Billion HKD | 0.98% |
| 2019 | 2.09 Billion HKD | 1198.51% |
| 2018 | 161.5 Million HKD | -11.83% |
| 2017 | 183.17 Million HKD | 7.93% |
| 2016 | 169.71 Million HKD | 9.66% |
| 2015 | 154.76 Million HKD | 2.23% |
| 2014 | 151.38 Million HKD | 2.81% |
| 2013 | 147.25 Million HKD | -3.39% |
| 2012 | 152.41 Million HKD | 35.17% |
| 2011 | 112.76 Million HKD | 18.16% |
| 2010 | 95.42 Million HKD | 34.21% |
| 2009 | 71.1 Million HKD | -11.95% |
| 2008 | 80.75 Million HKD | -16.99% |
| 2007 | 97.27 Million HKD | 45.06% |
| 2006 | 67.05 Million HKD | 0.15% |
| 2005 | 66.95 Million HKD | -2.81% |
| 2004 | 68.89 Million HKD | 107.78% |
| 2003 | 33.15 Million HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 1.61 Billion HKD | 0.0% |
| 2023 FY | 308.09 Million HKD | -81.17% |
| 2023 Q4 | 308.09 Million HKD | 0.0% |
| 2022 Q2 | 1.65 Billion HKD | 0.0% |
| 2022 FY | 1.63 Billion HKD | -12.43% |
| 2022 Q4 | 1.63 Billion HKD | 0.0% |
| 2021 Q4 | 1.86 Billion HKD | 0.0% |
| 2021 Q2 | 2.02 Billion HKD | 0.0% |
| 2021 FY | 1.86 Billion HKD | -11.75% |
| 2020 Q4 | 2.11 Billion HKD | 0.0% |
| 2020 FY | 2.11 Billion HKD | 0.98% |
| 2020 Q2 | 2.1 Billion HKD | 0.0% |
| 2019 FY | 2.09 Billion HKD | 1198.51% |
| 2019 Q2 | 201.08 Million HKD | 0.0% |
| 2019 Q4 | 2.09 Billion HKD | 0.0% |
| 2018 Q4 | 161.5 Million HKD | 0.0% |
| 2018 Q2 | 200.21 Million HKD | 0.0% |
| 2018 FY | 161.5 Million HKD | -11.83% |
| 2017 FY | 183.17 Million HKD | 7.93% |
| 2017 Q2 | 196.48 Million HKD | 0.0% |
| 2017 Q4 | 183.17 Million HKD | 0.0% |
| 2016 Q4 | 169.71 Million HKD | 0.0% |
| 2016 Q2 | 168.39 Million HKD | 0.0% |
| 2016 FY | 169.71 Million HKD | 9.66% |
| 2015 Q4 | 154.76 Million HKD | 0.0% |
| 2015 Q2 | 166.85 Million HKD | 0.0% |
| 2015 FY | 154.76 Million HKD | 2.23% |
| 2014 Q3 | 151.38 Million HKD | -5.92% |
| 2014 FY | 151.38 Million HKD | 2.81% |
| 2014 Q1 | 160.9 Million HKD | 9.27% |
| 2014 Q4 | 151.38 Million HKD | 0.0% |
| 2014 Q2 | 160.9 Million HKD | 0.0% |
| 2013 Q1 | 183.2 Million HKD | 20.2% |
| 2013 Q4 | 147.25 Million HKD | 0.0% |
| 2013 FY | 147.25 Million HKD | -3.39% |
| 2013 Q3 | 147.25 Million HKD | -19.62% |
| 2013 Q2 | 183.2 Million HKD | 0.0% |
| 2012 Q1 | 160.75 Million HKD | 42.56% |
| 2012 Q4 | 152.41 Million HKD | 0.0% |
| 2012 Q3 | 152.41 Million HKD | -5.18% |
| 2012 FY | 152.41 Million HKD | 35.17% |
| 2012 Q2 | 160.75 Million HKD | 0.0% |
| 2011 Q4 | 112.76 Million HKD | 0.0% |
| 2011 FY | 112.76 Million HKD | 18.16% |
| 2011 Q2 | 143.77 Million HKD | 0.0% |
| 2010 FY | 95.42 Million HKD | 34.21% |
| 2010 Q2 | 93.69 Million HKD | 0.0% |
| 2010 Q4 | 95.42 Million HKD | 0.0% |
| 2009 Q4 | 71.1 Million HKD | 0.0% |
| 2009 FY | 71.1 Million HKD | -11.95% |
| 2008 FY | 80.75 Million HKD | -16.99% |
| 2007 FY | 97.27 Million HKD | 45.06% |
| 2006 FY | 67.05 Million HKD | 0.15% |
| 2005 FY | 66.95 Million HKD | -2.81% |
| 2004 FY | 68.89 Million HKD | 107.78% |
| 2003 FY | 33.15 Million HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -2426.015% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 77.813% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -4140.853% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 28.646% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -3.352% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -390.431% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -213.535% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -75.457% |
| SSY Group Limited | 1.08 Billion HKD | 71.637% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -236.407% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 3.07% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.122% |